Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / GENOMICS AND BIO
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
300K
-
Shares change
-
+300K
-
Total reported value, excl. options
-
$11.7M
-
Value change
-
+$11.7M
-
Number of buys
-
42
-
Price
-
$38.83
Significant Holders of GLOBAL X FDS - GENOMICS AND BIO (GNOM) as of Q3 2025
42 filings reported holding GNOM - GLOBAL X FDS - GENOMICS AND BIO as of Q3 2025.
GLOBAL X FDS - GENOMICS AND BIO (GNOM) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 300K shares
.
Largest 10 shareholders include FLOW TRADERS U.S. LLC (46K shares), BANK OF AMERICA CORP /DE/ (36.9K shares), LPL Financial LLC (32.7K shares), OPPENHEIMER ASSET MANAGEMENT INC. (22K shares), IHT Wealth Management, LLC (19.4K shares), UBS Group AG (16.3K shares), JANE STREET GROUP, LLC (14.9K shares), Insight Advisors, LLC/ PA (14.9K shares), Stratos Wealth Partners, LTD. (14.6K shares), and CREATIVE FINANCIAL DESIGNS INC /ADV (11.6K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.